# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000320017-23-000022
Filing Date
2023-05-01
Accepted
2023-05-01 16:02:34
Documents
7
Period of Report
2023-05-01

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | def14a-2023.htm | DEF 14A | 827329
2 |  | djmnew.jpg | GRAPHIC | 7742
3 |  | image1a.jpg | GRAPHIC | 74478
4 |  | imagea.jpg | GRAPHIC | 64649
5 |  | lisata.jpg | GRAPHIC | 16409
6 |  | proxycard04202023_pagex1.jpg | GRAPHIC | 484549
7 |  | proxycardpage204252023.jpg | GRAPHIC | 396977
| Complete submission text file | 0000320017-23-000022.txt |  | 2266953

Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33650 | Film No.: 23873467
SIC: 8090 Services-Misc Health & Allied Services, NEC